New mutation of pelizaeus--merzbacher-like disease; a report from iran

Parvaneh Karimzadeh1, Farzad Ahmadabadi2, Omid Aryani3

  • 1Pediatric Neurology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Pelizaeus-Merzbacher-like disease (PMLD) is a rare neurological disorder. A novel GJA12 gene mutation, c.902-918Del, was identified in a child with PMLD, suggesting increased prevalence in the Middle East.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Pelizaeus-Merzbacher-like disease (PMLD) is a rare, inherited hypomyelinating leukoencephalopathy.
  • Mutations in the GJA12/GJC2 gene are known to cause autosomal recessive forms of PMLD.

Observation:

  • A case study of a 10-month-old girl presenting with nystagmus, psychomotor delay, hypotonicity, head nodding, and dysmyelination.
  • The patient's parents were healthy second cousins, indicating a potential for recessive inheritance.

Findings:

  • Genetic analysis revealed a novel homozygous deletion, c.902-918Del, in exon 2 of the GJA12 gene.
  • This specific mutation has not been previously reported in scientific literature.

Implications:

  • The findings suggest that GJA12 gene mutations may be more prevalent in the Middle East population.
  • This discovery contributes to understanding the genetic heterogeneity of PMLD and highlights the need for broader genetic screening.